Compare RITM & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RITM | NOVT |
|---|---|---|
| Founded | 2011 | 1968 |
| Country | United States | United States |
| Employees | 6045 | N/A |
| Industry | Real Estate Investment Trusts | Industrial Machinery/Components |
| Sector | Real Estate | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.9B |
| IPO Year | N/A | 1999 |
| Metric | RITM | NOVT |
|---|---|---|
| Price | $9.03 | $118.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 1 |
| Target Price | $14.56 | ★ $133.00 |
| AVG Volume (30 Days) | ★ 10.8M | 406.8K |
| Earning Date | 04-24-2026 | 05-05-2026 |
| Dividend Yield | ★ 11.40% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.47 |
| Revenue | N/A | ★ $521,290,000.00 |
| Revenue This Year | N/A | $8.71 |
| Revenue Next Year | $5.52 | $6.47 |
| P/E Ratio | ★ $10.21 | $77.16 |
| Revenue Growth | N/A | ★ 35.49 |
| 52 Week Low | $8.43 | $98.27 |
| 52 Week High | $12.74 | $149.95 |
| Indicator | RITM | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 30.98 | 40.08 |
| Support Level | N/A | $111.49 |
| Resistance Level | $11.24 | $126.36 |
| Average True Range (ATR) | 0.31 | 5.72 |
| MACD | -0.05 | -1.19 |
| Stochastic Oscillator | 35.63 | 22.31 |
Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights), loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.